Morbidity and mortality in South African gold miners: Impact of untreated disease due to human immunodeficiency virus

被引:140
作者
Corbett, EL
Churchyard, GJ
Charalambos, S
Samb, B
Moloi, V
Clayton, TC
Grant, AD
Murray, J
Hayes, RJ
De Cock, KM
机构
[1] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London, England
[2] Hop Natl St Maurice, INSERM, U88, St Maurice, France
[3] Ernest Oppenheimer Hosp, Aurum Hlth Res, Welkom, South Africa
[4] Univ Witwatersrand, Dept Community Hlth, Natl Ctr Occupat Hlth, ZA-2001 Johannesburg, South Africa
基金
英国惠康基金;
关键词
D O I
10.1086/339540
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A cohort of 1792 human immunodeficiency virus (HIV)-positive and 2970 HIV-negative South African miners was observed for 12 months starting in February 1998. All-cause hospitalizations and deaths were significantly associated with HIV infection (respective unadjusted incidence rate ratios, 2.9 and 9.2; respective 95% confidence intervals, 2.5-3.4 and 5.5-16.0). Tuberculosis (TB), bacterial pneumonia, cryptococcosis, and trauma were the major causes of admission for HIV-positive patients, whereas Pneumocystis carinii pneumonia was an uncommon cause (respective admission rates, 8.5, 6.9, 2.2, 6.0, and 0.53 admissions per 100 person-years). Enteritis, bronchitis, urinary tract infections, and soft-tissue infections were also significantly associated with HIV infection. Cryptococcosis caused 44% of deaths among HIV-positive patients. Trauma was the main hazard for HIV-negative men, causing 42% of admissions and 60% of deaths. A broad range of infectious conditions is significantly associated with HIV infection in South African miners. Identification and implementation of effective prophylactic regimens are urgently needed.
引用
收藏
页码:1251 / 1258
页数:8
相关论文
共 32 条
  • [1] Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote d'Ivoire:: a randomised trial
    Anglaret, X
    Chêne, G
    Attia, A
    Toure, S
    Lafont, S
    Combe, P
    Manlan, K
    N'Dri-Yoman, T
    Salamon, R
    [J]. LANCET, 1999, 353 (9163) : 1463 - 1468
  • [2] [Anonymous], 1992, MMWR-MORBID MORTAL W, V41, P1
  • [3] Bergemann A, 1996, QJM-MON J ASSOC PHYS, V89, P499
  • [4] Boerma JT, 1998, AIDS, V12, pS3
  • [5] BORGDORFF MW, 1995, GENITOURIN MED, V71, P212
  • [6] Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials
    Bucher, HC
    Griffith, LE
    Guyatt, GH
    Sudre, P
    Naef, M
    Sendi, P
    Battegay, M
    [J]. AIDS, 1999, 13 (04) : 501 - 507
  • [7] *CHAMB MIN S AFR, 1999, ANN REP 1980 1999
  • [8] CHARALAMBOS S, 2002, IN PRESS S AFR J EPI
  • [9] Churchyard CJ, 1999, INT J TUBERC LUNG D, V3, P791
  • [10] HIV infection and silicosis: the impact of two potent risk factors on the incidence of mycobacterial disease in South African miners
    Corbett, EL
    Churchyard, GJ
    Clayton, TC
    Williams, BG
    Mulder, D
    Hayes, RJ
    De Cock, KM
    [J]. AIDS, 2000, 14 (17) : 2759 - 2768